BRMBristol-Myers Squibb Company
56.70EUR-1.90%Mkt Cap: 127.16B $P/E: 14.61

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology, hematology, immunology, cardiovasc…

Key Statistics

Company
Market Cap127.16B $
Enterprise Value164.10B $
Revenue (TTM)53.46B $
Gross Profit37.24B $
Net Income (TTM)7.67B $
Revenue/Share26.24 USD
Last Price56.70 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees32.5K
CountryDE
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN
Valuation
P/E (Trailing)14.61
P/E (Forward)
PEG2.37
EV/EBITDA7.97
EV/Revenue3.07
P/S2.38
P/B6.07
EPS (TTM)3.92
EPS (Forward)
52W Range
56.3016% of range58.77
52W High58.77 EUR
52W Low56.30 EUR
Profitability
Gross Margin71.08%
Oper. Margin34.42%
EBITDA Margin38.49%
Profit Margin14.64%
ROE38.19%
ROA7.83%
Growth
Revenue Growth5.70%
Earnings Growth153.10%
Cash Flow & Leverage
Operating CF15.39B $
CapEx (TTM)1.43B $
FCF Margin16.50%
FCF Yield6.94%
Net Debt36.94B $
Net Debt/EBITDA1.80
Balance Sheet
Debt/Equity2.55
Current Ratio1.53
Quick Ratio1.29
Book Value/Sh9.438 EUR
Cash/Share5.418 EUR
Dividends
Fwd Div Rate2.180 EUR
Trail. Div Rate2.510 EUR
Div. Yield3.78%
5Y Avg Yield3.99%
Payout Ratio55.29%
Ex-Div DateJul 2, 2026
Pay Date
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.2.04B
Float2.04B
Insiders0.10%
Institutions84.69%
Technical
SMA 5052.38 (+8.2%)
SMA 20049.33 (+14.9%)
Beta0.23
S&P 52W Chg18.16%
Avg Vol (30d)901
Avg Vol (10d)1.49K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)